Ocriplasmin Effective in Resolving VMT and Closing Macular Holes
ThromboGenics NV announced that the data from two
phase 3 clinical trials evaluating ocriplasmin for the treatment
of vitreomacular traction (VMT) and macular hole
were published in the emNew England Journal of Medicine/em.sup1/sup
The article highlights that a single intravitreal injection
of ocriplasmin resolved vitr...